secwatch.observer — SEC 8-K summary
======================================

Issuer:     ATOSSA THERAPEUTICS, INC. (ATOS)
CIK:        0001488039
Form:       8-K
Filed at:   2024-03-18T23:59:59+00:00
Accession:  0000950170-24-032535
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Atossa regains Nasdaq minimum bid price compliance; stock remains listed
------------------------------------------------------------------------

- Received Nasdaq letter on March 15, 2024 confirming regained compliance with Listing Rule 5550(a)(2).
- Previously notified of deficiency on Sep 26, 2023 for failing to maintain $1.00 minimum closing bid for 30 consecutive days.
- Regained compliance by achieving $1.00 closing bid for 10 consecutive trading days ending March 14, 2024.
- No further delisting risk; common stock continues trading on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1488039/000095017024032535/0000950170-24-032535-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1488039/000095017024032535/atos-20240315.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-032535

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer